Common pathway signature in lung and liver fibrosis

Eugene MakarevAtlas Regeneration, Inc., Winston-Salem, NC, USA;Insilico Medicine, Inc., ETC, Johns Hopkins University, Baltimore, MD, USACorrespondence[email protected]

Evgeny IzumchenkoDepartment of Otolaryngology-Head & Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Fumiaki AiharaAdvanced Academic Programs, Johns Hopkins University, Baltimore, MD, USA

Piotr T. WysockiDepartment of Otolaryngology-Head & Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Qingsong ZhuInsilico Medicine, Inc., ETC, Johns Hopkins University, Baltimore, MD, USA

Anton BuzdinThe Biogerontology Research Foundation, London, UK

David SidranskyDepartment of Otolaryngology-Head & Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Alex ZhavoronkovInsilico Medicine, Inc., ETC, Johns Hopkins University, Baltimore, MD, USA;Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA

Anthony AtalaAtlas Regeneration, Inc., Winston-Salem, NC, USA;Pathway Pharmaceuticals, Ltd, Hong Kong, Hong Kong

show all

Common pathway signature in lung and liver fibrosis

Supplemental Files

Related Research Data

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Common pathway signature in lung and liver fibrosis

Supplemental Files

Related Research Data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date